![(6s)-6-(2-Tert-butoxy-2-oxoethyl)-4-(4-chlorophenyl)-2,3,9-trimethyl-6,7-dihydrothieno[3,2-F][1,2,4]triazolo[4,3-A][1,4]diazepin-10-ium](https://static.cymitquimica.com/cas-image/1661-6s-6-2-tert-butoxy-2-oxoethyl-4-4-chlorophenyl-239-trimethyl-67-dihydrothieno-32-f-124-triazolo-43-a-14-diazepin-10-ium.png)
CAS: 1268524-70-4 - (6s)-6-(2-Tert-butoxy-2-oxoethyl)-4-(4-chlorophenyl)-2,3,9-trimethyl-6,7-dihydrothieno[3,2-F][1,2,4]triazolo[4,3-A][1,4]diazepin-10-ium
Formula:C23H25ClN4O2S
InChI:InChI=1S/C23H25ClN4O2S/c1-12-13(2)31-22-19(12)20(15-7-9-16(24)10-8-15)25-17(11-18(29)30-23(4,5)6)21-27-26-14(3)28(21)22/h7-10,17H,11H2,1-6H3/t17-/m0/s1
InChI key:InChIKey=DNVXATUJJDPFDM-KRWDZBQOSA-N
SMILES:O=C(OC(C)(C)C)CC1N=C(C=2C=CC(Cl)=CC2)C3=C(SC(=C3C)C)N4C(=NN=C41)C
- Synonyms:
- (+)-Jq1
- (S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
- (S)-Jq1
- 1,1-Dimethylethyl (6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetate
- 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-trimethyl-, 1,1-dimethylethyl ester, (6S)-
- BET domain inhibitor JQ1
- Bromodomain and extra-terminal domain inhibitor JQ1
- JQ1 (BET inhibitor)
- JQ1 (pharmaceutical)
- Jq-1
- See more synonyms
- tert-Butyl (S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
Ref: 7W-GW0962
| 1mg | 324.00 € | |
| 5mg | 524.00 € | |
| 10mg | 853.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
(+)-JQ-1
CAS:1268524-70-4
(+)-JQ-1 (JQ1) is a BET bromine domain inhibitor that inhibits BRD4 (1/2) (IC50=77/33 nM) with …
Formula:
C23H25ClN4O2S
Purity:
99.97%
Color and Shape:
Solid
Molecular weight:
456.99
Ref: TM-T2110
| 1g | 723.00 € | |
| 2mg | 44.00 € | |
| 5mg | 59.00 € | |
| 10mg | 78.00 € | |
| 25mg | 94.00 € | |
| 50mg | 142.00 € | |
| 100mg | 185.00 € | |
| 500mg | 504.00 € | |
| 1ml*10 (DMSO) | 66.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Ref: 4Z-K-031040
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 9 May 2024
![(S)-(+)-Tert-butyl 2-(4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate](https://static.cymitquimica.com/products/TR/thumb/T117580.jpg)
(S)-(+)-Tert-butyl 2-(4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
CAS:1268524-70-4
Applications BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation. References …
Formula:
C23H25ClN4O2S
Color and Shape:
Light Yellow Solid
Molecular weight:
456.99
Ref: TR-T117580
| 5mg | 89.00 € | |
| 25mg | 171.00 € | |
| 100mg | 425.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
(+)-JQ 1
Controlled ProductCAS:1268524-70-4
Potent BET inhibitor with high specificity for acetyl-lysine recognition motifs found in the BET family …
Formula:
C23H25ClN4O2S
Purity:
Min. 95%
Color and Shape:
White Powder
Molecular weight:
456.99 g/mol
Ref: 3D-FC43273
| 2mg | 105.00 € | |
| 5mg | 162.00 € | |
| 10mg | 254.00 € | |
| 50mg | 743.00 € | |
| 250mg | 1,066.00 € |
Estimated delivery in United States, on Monday 13 May 2024
